INTRODUCTION
============

Both acute and chronic exposure to air pollution are known to have detrimental effects on cardiorespiratory health \[[@b1-jpmph-51-3-130]\]. Worsening air pollution in northeast Asia, including Korea and Japan, is believed to be due to long-range transport of air pollutants from industrialized areas of mainland China \[[@b2-jpmph-51-3-130],[@b3-jpmph-51-3-130]\], as well as domestic sources of air pollution such as motor vehicles, industry, and open burning \[[@b4-jpmph-51-3-130],[@b5-jpmph-51-3-130]\]. In addition to anthropogenic air pollutants, a natural phenomenon known as Asian sand dust (ASD) causes air pollution in East Asia. ASD particles originating from inland China, including the Gobi and Taklamakan deserts and the Loess Plateau, are transported to East Asia with the westerlies and monsoon mainly in the spring, accompanied by pollutants produced in industrial areas on the east coast of China \[[@b6-jpmph-51-3-130],[@b7-jpmph-51-3-130]\]. Ambient nitrate and sulfate concentrations have been reported to remain high, accompanied by long-lasting high ambient particulate matter (PM) concentrations, during ASD events in Korea and Japan \[[@b8-jpmph-51-3-130]\]. Lee et al. \[[@b9-jpmph-51-3-130]\] reported that the microbial profiles of ambient particles during ASD events were distinctive from those observed during non-ASD events, suggesting that ASD might cause adverse health effects in areas covered with ASD particles. PM air pollution has been reported to have health effects in terms of mortality and morbidity from cardiorespiratory diseases, respiratory symptoms, and hospital admissions \[[@b10-jpmph-51-3-130]-[@b13-jpmph-51-3-130]\]. In the estimation of effects on the atmospheric environment, which is intimately involved in daily life, objective and clinical endpoints, as well as a multifaceted evaluation including a subjective measure of impact, are desirable. Therefore, the concept of health-related quality of life (HR-QoL), which refers to an individual's perception of well-being, should also be considered as a health outcome of exposure to air pollution \[[@b14-jpmph-51-3-130]\]. Although Yamazaki et al. \[[@b15-jpmph-51-3-130]\] reported a significant linear trend of lower HR-QoL vitality scores on the Short Form-36 Health Survey (SF-36) in groups exposed to higher concentrations of nitrogen oxides in Japan, few studies have investigated the effects of air pollution on HR-QoL in Korea.

To elucidate the association of air pollution levels with patients' reported respiratory symptoms and HR-QoL, we conducted a hospital-based panel study of patients with or without chronic obstructive pulmonary disease (COPD) living in Dongtan, Hwaseong, which is 30-40 km south of Seoul.

METHODS
=======

Study Design and Participants
-----------------------------

This institution-based panel study was conducted among Korean adults at Hallym University Dongtan Sacred Heart Hospital in Hwaseong, Gyeonggi Province, Korea. Patients aged 40-79 years visiting the hospital in February from 2013 to 2015 were recruited, and a different set of patients was established each year. Outpatients with COPD were diagnosed by a respiratory specialist with reference to the results of a pulmonary function test. Patients with COPD in a stable state (not in an exacerbation state or undergoing home oxygen therapy) were classified as having COPD according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria \[[@b16-jpmph-51-3-130]\]. Participants with no respiratory diseases were classified as the referent group. Participants filled out a questionnaire at enrollment in February and were followed up in May and July, when the questionnaire was administered. In February, a total of 75 patients with COPD and 90 referents were included. The follow-up rates of COPD and referent groups measured against the initial February enrollment were 90.7% (n= 68) and 88.9% (n= 80), respectively, in May and 84.0% (n= 63) and 83.3% (n= 75), respectively, in July.

Ethical Approval and Consent to Participate

This study was approved by the clinical ethical review board of Kurume University School of Medicine and Hallym University Dongtan Sacred Heart Hospital. Before the investigation, participants were provided with an explanation in person regarding the purpose and method of the study, as well as information regarding data handling. The study was carried out upon receipt of written consent.

Questionnaire
-------------

The questionnaire was a self-completed booklet containing items on demographics and lifestyle such as age, sex, smoking history, occupation, and respiratory symptoms (Q1: Does the weather affect your cough?; Q2: Have you ever coughed up sputum from your chest when you did not have a cold?; Q3: Do you usually cough up sputum from your chest first thing in the morning?; and Q4: How frequently do you wheeze?), the Dartmouth Coop Functional Health Assessment/World Organization of National Colleges, Academies, and Academic Association of General Practitioners (COOP/WONCA) charts, and the SF-36 version 2 (SF-36v2). Permission for the use of the Korean version of the COOP/WANCA charts was obtained from Van Weel \[[@b17-jpmph-51-3-130]\], and permission for the use of the Korean version of the SF-36v2 was licensed from QualityMetric Incorporated (New York, NY, USA). The validity and reliability of the Korean versions of the SF-36v2 and COOP/WONCA charts have previously been demonstrated \[[@b18-jpmph-51-3-130]-[@b20-jpmph-51-3-130]\]. Responses to the COOP/WONCA charts, which comprised 8 items (physical fitness, feelings, daily activities, social activities, change in health, overall health, pain, and quality of life), were scored on a 5-point ordinal scale (1=best; 5=worst) \[[@b17-jpmph-51-3-130]\]. The scores of the COOP/WANCA charts were inverted (5=best; 1=worst) to facilitate interpretation. Responses to the SF-36v2, which comprised 36 questions, were on 3-, 5-, or 6-point ordinal scales, from which 8 subscales (physical functioning, role limitations due to physical health problems \[role: physical\], bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems \[role: emotional\], mental health) from 0 to 100 points (minimum=0, maximum= 100) were calculated according to the scoring manual \[[@b21-jpmph-51-3-130]\].

Sources of Air Quality Data
---------------------------

Air quality data, including PM less than 10 μm in diameter (PM~10~), PM less than 2.5 μm in diameter (PM~2.5~), nitrogen dioxide (NO~2~), sulfate dioxide (SO~2~), ozone (O~3~), and carbon monoxide (CO) data were obtained from a monitoring station in Dontang-dong, Hwaseong, which was the nearest station to the hospital, according to the Gyeonggi-do Institute of Health and Environment \[[@b22-jpmph-51-3-130]\]. Ambient temperature and relative humidity (RH) were obtained from data collected at the nearest weather station to the hospital (37.267° east longitude and 126.983° north latitude) according to the National Oceanic and Atmospheric Administration, National Data Center climate data available online \[[@b23-jpmph-51-3-130]\]. Personal exposure to each pollutant, temperature, and humidity was based on the mean value at 4 weeks before survey enrollment. ASD events were defined according to the criteria used by the National Institute of Environmental Research \[[@b24-jpmph-51-3-130]\].

### Data handling and statistical analyses

Data were anonymized and managed electronically for analysis. Statistical analyses, including the Welch *t*-test, the chi-square test, and generalized estimating equation (GEE) analysis \[[@b25-jpmph-51-3-130]\], were performed using SPSS version 22.0 (IBM Corp., Armonk, NY, USA), and p\<0.05 were considered to indicate statistical significance. We chose a binary logistic model, which specifies a binominal as the distribution and logit as the link function, for GEE analysis and coded the COOP/WONCA chart scores (0=4 and 5 points; 1=1-3 points), SF-36v2 subscale scores (0=\>median; 1=≤median), and respiratory symptoms (Q1: weather affects your cough; Q2: coughing up sputum without cold; Q3: coughing up sputum first thing in the morning; Q4: frequent wheezing; 0=no \[Q1-Q3\] or never \[Q4\]; 1=yes \[Q1-Q3\] or occasionally/more often \[Q4\]) as dependent variables for the GEE analysis. In the crude model, pollutant concentrations (in 10 μg/m^3^ \[PM~10~, PM~2.5~\] or 10 parts per billion \[NO~2~, O~3~\] increments), ASD events during the past month (0=did not occur; 1=occurred), temperature (in 10°C increments), and RH (in 10% increments) were applied as covariates, and these variables were entered separately due to multicollinearity ([Table S1](#SD1){ref-type="supplementary-material"}). We applied the average concentrations of pollutants from 1 month before the day of entry because our questionnaires asked about subjects' health status during the past 2-4 weeks. SO~2~ and CO were excluded from the analysis because the concentrations of these compounds were much lower than Korean National Ambient Air Quality Standards \[[@b26-jpmph-51-3-130]\] ([Figure S1](#SD5){ref-type="supplementary-material"}). Age (years old), sex (0= female; 1=male), body mass index (0=\>median; 1=≤median), smoking status (0=never smoker; 1=ex-smoker; 2=current smoker), COPD severity (0=no COPD; 1=GOLD stage I; 2=GOLD stage II; 3=GOLD stages III and IV), use of air cleaning equipment (0=no; 1=yes), and time spent outdoors (hr/d) were applied as predictive variables in the adjusted model. In the adjusted model, ambient temperature and RH were also applied.

RESULTS
=======

Characteristics of Participants and Air Quality During Survey Period
--------------------------------------------------------------------

The characteristics of participants at the baseline (February) are presented in [Table 1](#t1-jpmph-51-3-130){ref-type="table"}. The mean age, male-to-female ratio, and smoking rate in the COPD group were significantly higher than in the referent group. A significant mean age difference was found only in male participants. Body mass index and employment were significantly lower in the COPD group than in the referent group. While hay fever and self-reported asthma were more prevalent in the COPD group than in the referent group, this difference was not significant. About half of the COPD patients were classified as GOLD stage II (moderate), after which GOLD stage I (mild), III (severe), and IV (very severe) were most prevalent, in decreasing order. Air quality and climate data during the survey period are summarized in [Table 2](#t2-jpmph-51-3-130){ref-type="table"} and [Figure S1](#SD5){ref-type="supplementary-material"}.

Comparison Of HR-QoL Scores and Respiratory Symptoms Between the COPD and Referent Groups
-----------------------------------------------------------------------------------------

[Table 3](#t3-jpmph-51-3-130){ref-type="table"} shows that for each month, physical fitness, overall health, and quality of life scores on the COOP/WONCA charts were significantly worse in the COPD group than in the referent group. Daily activity scores on the COOP/WONCA charts were only worse in the COPD group than in the referent group in July. In February, all SF-36v2 subscale scores excluding mental health scores were worse in the COPD group than in the referent group. Four kinds of respiratory symptoms were more prevalent in the COPD group than in the referent group, and the number of symptoms per participant was higher in the COPD group than in the referent group.

Factors Associated With Respiratory Symptoms, COOP/WONCA Chart Scores, and SF-36v2 Subscale Scores
--------------------------------------------------------------------------------------------------

The associations of ambient air quality with COOP/WONCA chart scores, SF-36v2 subscale scores, and respiratory symptoms were examined using GEE analysis ([Figure 1](#f1-jpmph-51-3-130){ref-type="fig"}). After adjusting for demographics, lifestyle, disease severity, temperature, and humidity, it was found that ASD events were associated with lower physical fitness COOP/WONCA chart scores. Increased PM~10~ concentrations were related to worse daily activity COOP/WONCA chart scores. The relationship between daily activities and PM~2.5~ parameters could not be examined because PM~2.5~ parameters did not fit this GEE model. Regarding the SF-36v2 subscales, higher PM~2.5~ and NO~2~ concentrations were associated with lower social functioning scores, and higher NO~2~ concentrations were correlated with lower mental health scores. Higher PM~10~, NO~2~, and O~3~ concentrations were related to affirmative answers to symptom Q1 (Does the weather affect your cough?), and higher PM~10~ concentrations were associated with affirmative answers to symptom Q4 (How frequently do you wheeze?).

DISCUSSION
==========

We conducted a hospital-based panel study of Korean adults to try to predict the impact of air pollution on 75 participants with COPD and 90 participants without respiratory diseases ([Table 1](#t1-jpmph-51-3-130){ref-type="table"}). We used GEE analysis to predict the association between air pollution and health status because this study consisted of an iterative survey. Some significant associations of air quality parameters with HR-QoL and respiratory symptoms were found in this study ([Figure 1](#f1-jpmph-51-3-130){ref-type="fig"}).

Children, elderly people, and patients with respiratory disorders are considered highly susceptible to air pollution \[[@b13-jpmph-51-3-130]\]. Morbidity, mortality, hospital admission, and cardiorespiratory symptoms were therefore analyzed as health outcomes of air pollution. Patients with COPD, which elderly people are prone to, presented a significant association between increased mortality and hospitalization due to disease exacerbation from short-term exposure to ambient fine PM \[[@b27-jpmph-51-3-130]\]. In addition to clinical and objective endpoints, HR-QoL changes should also be considered as a health outcome of exposure to air pollution \[[@b14-jpmph-51-3-130]\]. Although few reports have investigated the relationship between air pollution and HR-QoL, Yamazaki et al. \[[@b15-jpmph-51-3-130],[@b28-jpmph-51-3-130]\] reported that higher nitrogen oxide and oxidant concentrations were associated with lower vitality scores on the SF-36 in Japan. Our previous study showed that HR-QoL in Mongolian adults with respiratory diseases was worse in the cold season, when air pollution is severe \[[@b29-jpmph-51-3-130],[@b30-jpmph-51-3-130]\]. Kamimura et al. \[[@b31-jpmph-51-3-130]\] reported that perceived environmental pollution levels were associated with HR-QoL, but with different patterns among 3 East Asian countries (China, Japan, and Korea). These reports suggest that HR-QoL may be a useful measure to assess the impact of air pollution on public health, although international differences exist.

Seasonal variations in the clinical conditions of COPD have been reported, with more patients suffering exacerbations in winter \[[@b32-jpmph-51-3-130],[@b33-jpmph-51-3-130]\]. Miravitlles et al. \[[@b34-jpmph-51-3-130]\] reported that HR-QoL in COPD patients was better in spring/summer than in the winter. In the present study, temperature and humidity were included as independent variables in the model to analyze seasonal factors. Higher temperatures were significantly associated with worse scores of physical functioning, role: physical, and general health perception subscales of the SF-36v2, while the COOP/WONCA daily activities score worsened in association with lower temperatures ([Figure 1](#f1-jpmph-51-3-130){ref-type="fig"}). Our results are not consistent with previous reports \[[@b32-jpmph-51-3-130]-[@b34-jpmph-51-3-130]\], except for the COOP/WONCA daily activities score. We speculate that this inconsistency is attributable to the survey being started in winter. Only COPD patients in a stable state even in winter were included, so this set of patients may not have been susceptible to exacerbation. The cause of the association between higher temperatures and worse HR-QoL remains unclear.

ASD events were significantly associated with lower physical fitness scores on the COOP/WONCA charts, even after adjustment ([Figure 1](#f1-jpmph-51-3-130){ref-type="fig"}). COOP/WONCA physical fitness scores were also associated with COPD severity, suggesting that physical fitness in the COPD patients was more vulnerable to exposure to ASD events than in the referent group. The association of COOP/WONCA daily activity scores with PM~10~ was independent of COPD severity. All SF-36v2 subscales were significantly associated with COPD severity. Additionally, social functioning subscale scores on the SF-36v2 were related to PM~2.5~ and NO~2~ concentrations, suggesting that social functioning in the COPD group was more vulnerable to exposure to these pollutants than in the referent group. The "weather affects your cough" symptom was associated with PM~10~, NO~2~, and O~3~ concentrations but not with COPD severity, while the "frequent wheezing" symptom was correlated with PM~10~ and COPD severity. These results suggest that PM~10~ and gaseous pollutants such as NO~2~ and O~3~ cause weather-related cough, leading to the deterioration of daily activities, and this cascade of reaction to PM~10~ exposure is suggested to occur independently of COPD. In contrast, PM~10~ is also suggested to cause wheezing, leading to the deterioration of physical fitness and social functioning, and COPD patients appear to be more susceptible to PM~10~ than those without COPD. PM~2.5~ was also associated with frequent wheezing after adjustment, but not to a significant extent. ASD events were not significantly associated with any symptoms, though they were associated with the HR-QoL physical fitness score. The main component of ASD is soil-derived PM, including PM~10~, and PM~2.5~ \[[@b35-jpmph-51-3-130]\]. Therefore, ASD events might have some impact on symptoms such as coughing and wheezing, thereby worsening the daily activity, physical fitness, and social functioning aspects of HR-QoL. Additionally, increased O~3~ concentrations were associated with weather-related cough, independent of COPD severity. However, O~3~ did not show any adverse effects on HR-QoL---instead, lower O~3~ concentrations were associated with lower COOP/WONCA physical fitness scores in an obscure way. Since O~3~ is a substance temporarily produced due to the interaction of volatile organic compounds or nitrogen oxides with ultraviolet rays \[[@b36-jpmph-51-3-130]\], the association of NO~2~ with social functioning and mental health might be related to fluctuations in ambient O~3~ concentrations. The differences in the effects of gaseous pollutants and PM on respiratory symptoms might be explained in terms of the physical and chemical properties of these pollutants and pathophysiological and physiological differences between the participants with and without chronic respiratory diseases \[[@b37-jpmph-51-3-130],[@b38-jpmph-51-3-130]\].

There were several limitations of this study. First, the sample size was relatively small, which may be why few parameters showed a significant association with symptoms and HR-QoL scores. Second, since this was a panel study, the participants were not strictly followed. The causal relationship between HR-QoL and air quality parameters remains unclear, although more insight was obtained through comparisons with cross-sectional studies. Third, although the odds ratios were adjusted for various factors to estimate the association of environmental exposure with symptoms and HR-QoL in the GEE analysis, unknown confounders may have been present because this study was conducted with a small sample. Finally, although air quality data were obtained from monitoring stations near the hospital, it was impossible to verify a consistent relationship between each participant's range of movement and the location of the station. To evaluate the relationship between air pollution and health outcomes accurately, it would be necessary to measure indoor air quality and personal exposure to air pollution.

In conclusion, this study reported that PM air pollution may cause respiratory symptoms, leading to HR-QoL deterioration, in a sample of Korean participants. While some adverse effects of air pollution appeared to occur regardless of COPD, others appeared to occur more often and with greater severity among COPD patients. The public sector, therefore, needs to consider tailoring air pollution countermeasures to people with different health conditions to minimize adverse health effects.

This study was supported in part by Grants-in-Aid for Scientific Research (B) 20406001, 23406001, and (C) 26340053, and a MEXT-Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology, Japan, in the design of the study; collection, analysis, and interpretation of data; and in writing the manuscript.

We would like to thank the staff at Hallym University Dongtan Sacred Heart Hospital for their cooperation during our study in Korea. We also would like to express our appreciation for Dr. Keiko Yamauchi, Dr. Go Hasegawa, Ms. Tomoe Terasaki, and Ms. Ayumi Narumi of Kurume University for their technical support in data processing and manuscript preparation.

**CONFLICT OF INTEREST**

The authors have no conflicts of interest associated with the material presented in this paper.

SUPPLEMENTAL MATERIALS
======================

###### 

Supplementary Material 1: Table S1 is available at <https://www.jpmph.org/>.

###### 

Supplementary Material 2: Table S2 is available at <https://www.jpmph.org/>.

###### 

Supplementary Material 3: Table S3 is available at <https://www.jpmph.org/>.

###### 

Supplementary Material 4: Table S4 is available at <https://www.jpmph.org/>.

###### 

Supplementary Material 5: Figure S1 is available at <https://www.jpmph.org/>.

![Factors associated with COOP/WONCA chart scores (A), SF-36v2 subscale scores (B), and respiratory symptoms (C) analyzed by generalized estimating equations. Data are presented as odds ratios (ORs) (black square, crude OR; white square, adjusted OR) with 95% confidence intervals. Crude ORs show the associa- tions between pollutant concentrations (in 10 µg/m^3^ \[PM~10~, PM~2.5~\] or 10 ppb \[NO~2~, O~3~\] increments), ASD events during the past month, temperature (in 10°C incre- ments), or RH (in 10% increments) and the dependent variables. The adjusted ORs were adjusted for age, sex, body mass index, smoking status, COPD severity, use of air cleaning equipment, time spent outdoors, ambient temperature, and RH. Adjusted ORs of COPD severity are presented on the right side of each panel. De- tailed data are presented in [Tables S2](#SD2){ref-type="supplementary-material"}-[S4](#SD4){ref-type="supplementary-material"}. COOP-WONCA, Dartmouth Coop Functional Health Assessment/World Organization of National Colleges, Academies, and Academic Association of General Practitioners; SF-36v2, Short Form-36 Health Survey version 2; COPD, chronic obstructive pulmonary disease; RH, relative humidity; PM~10~, particulate matter less than 10 μm in diameter; PM~2.5~, particulate matter less than 2.5 μm in diameter; NO~2~, nitrogen dioxide; O~3~, ozone; ASD, Asian sand dust; ppb, parts per billion. \**p*\<0.05.](jpmph-51-3-130f1){#f1-jpmph-51-3-130}

###### 

Characteristics of participants at baseline, 2013-2015

  Characteristics            COPD patients (n = 75)   Referents (n = 90)   *p*-value
  -------------------------- ------------------------ -------------------- ---------------------------------------------------------
  Age (y)                                                                  
   Overall                   66.6±8.7                 59.8±6.1             \<0.001^[1](#tfn1-jpmph-51-3-130){ref-type="table-fn"}^
   Male                      66.5±8.7                 56.0±4.2             \<0.001^[1](#tfn1-jpmph-51-3-130){ref-type="table-fn"}^
   Female                    70.0±7.2                 62.4±5.8             0.20^[1](#tfn1-jpmph-51-3-130){ref-type="table-fn"}^
  BMI (kg/m^2^)              22.3±3.2                 23.8±2.9             0.002^[1](#tfn1-jpmph-51-3-130){ref-type="table-fn"}^
  Sex                                                                      
   Male                      72 (96.0)                36 (40.0)            \<0.001^[2](#tfn2-jpmph-51-3-130){ref-type="table-fn"}^
   Female                    3 (4.0)                  54 (60.0)            
  Smoking status                                                           
   Current smoker            24 (32.0)                14 (15.6)            
   Ex-smoker                 41 (54.7)                11 (12.2)            \<0.001^[2](#tfn2-jpmph-51-3-130){ref-type="table-fn"}^
   Never smoker              10 (13.3)                65 (72.2)            
  Occupation                                                               
   White-collar              5 (6.7)                  11 (12.2)            
   Blue-collar               25 (33.3)                71 (78.9)            \<0.001^[2](#tfn2-jpmph-51-3-130){ref-type="table-fn"}^
   Retired or unemployed     45 (60.0)                8 (8.9)              
  Prevalence                                                               
   Hay fever                 5 (6.7)                  1 (1.1)              0.06^[2](#tfn2-jpmph-51-3-130){ref-type="table-fn"}^
   Self-reported asthma      5 (6.7)                  1 (1.1)              0.06^[2](#tfn2-jpmph-51-3-130){ref-type="table-fn"}^
  COPD status (GOLD stage)                                                 
   I                         18 (24.0)                                     
   II                        36 (48.0)                                     
   III                       17 (22.7)                                     
   IV                        4 (5.3)                                       

Values are presented as mean±standard deviation or number (%).

COPD, chronic obstructive pulmonary disease; BMI, body mass index; GOLD, Global Initiative for Chronic Obstructive Lung Disease.

Welch *t*-test.

χ^2^-test.

###### 

Summary of air quality and climate data^[1](#tfn3-jpmph-51-3-130){ref-type="table-fn"}^ at each survey

  Variables               NAAQS   February    May                 July                                                                                                 
  ----------------------- ------- ----------- ------------------- ------------------ ----------- ------------------- ------------------ ----------- ------------------ ------------------
  Temperature (°C)        \-      0.8±3.9     0.8 (-11.8-8.5)     4.6 (-1.2-3.5)     18.0±3.2    18.5 (11.3-25.1)    4.1 (15.9-20.0)    25.5±1.6    25.6 (21.9-29.0)   2.4 (24.3-26.7)
  Relative humidity (%)   \-      63.4±14.6   63.4 (33.0-94.8)    21.1 (52.0-73.1)   65.5±14.1   64.6 (33.5-96.9)    18.2 (56.4-74.6)   79.9±10.6   79.8 (49.8-99.2)   16.2 (72.8-89.1)
  PM~2.5~ (µg/m^3^)       ≤50     35.0±23.6   26.1 (7.7-102.7)    32.1 (16.1-48.2)   26.4±10.3   23.8 (12.5-60.9)    9.1 (20.5-29.5)    23.4±14.4   18.4 (4.7-62.8)    17.6 (14.1-31.8)
  PM~10~ (µg/m^3^)        ≤100    62.0±56.2   46.9 (14.5-455.9)   34.9 (34.6-69.5)   55.9±23.5   50.1 (15.9-156.3)   24.2 (42.0-66.2)   35.0±17.3   30.8 (12.6-84.8)   22.5 (22.1-44.6)
  NO~2~ (ppb)             ≤60     29.8±10.6   27.5 (10.0-66.0)    15.0 (22.0-37.0)   19.0±7.6    18.0 (6.0-44.0)     9.0 (14.0-23.0)    12.5±4.6    11.0 (5.0-25.0)    6.0 (9.0-15.0)
  SO~2~ (ppb)             ≤50     6.2±2.1     6.0 (3.0-13.0)      2.0 (5.0-7.0)      5.0±1.4     5.0 (2.0-8.0)       2.0 (4.0-6.0)      3.3±1.0     3.0 (2.0-6.0)      1.0 (3.0-4.0)
  O~3~ (ppb)              ≤60     33.1±12.7   32.0 (10.0-70.0)    16.5 (24.3-40.8)   63.0±15.9   63.0 (26.0-107.0)   20.0 (51.0-71.0)   45.7±20.8   46.0 (5.0-87.0)    36.0 (28.5-64.5)
  CO (ppm)                ≤9      0.8±0.3     0.8 (0.3-1.7)       0.4 (0.6-1.0)      0.5±0.1     0.5 (0.2-0.9)       0.2 (0.4-0.6)      0.4±0.2     0.3 (0.1-1.0)      0.2 (0.3-0.5)

NAAQS, national air quality standard for daily mean (for PM~2.5~, PM~10~, NO~2~, and SO~2~) or daytime mean (for O~3~ and CO); SD, standard deviation; Min, minimum; Max, maximum; IQR, interquartile range; QT, quartile; PM~2.5~, particulate matter less than 2.5 μm in diameter; PM~10~, particulate matter less than 10 μm in diameter; NO~2~, nitrogen dioxide; SO~2~, sulfur dioxide; O~3~. ozone; CO, carbon monoxide; ppb, parts per billion; ppm, parts per million.

PM~2.5~, PM~10~, NO~2~, and SO~2~ are presented as monthly means of the daily average value; O~3~ and CO are presented as monthly means of the daily maximum value of the 8-hour moving average.

###### 

Comparison of HR-QoL scores and respiratory symptoms between COPD and referent groups in each season

                                                                                         February                     May                          July                                                                                                                                                                                                                                                                                                                                  
  -------------------------------------------------------------------------------------- ---------------------------- ---------------------------- ----------- --------------------------------------------------------- --------------------------------------------------------- ----------- --------------------------------------------------------- --------------------------------------------------------- ----------- --------------------------------------------------------- ---------------------------------------------------------
  COOP/WONCA charts (best: 5-worst: 1)^[2](#tfn5-jpmph-51-3-130){ref-type="table-fn"}^                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                         Physical fitness             4.2±1.1                      3.4±1.4     \<0.001                                                   4.3±0.9                                                   3.6±1.4     \<0.001                                                   4.3±0.9                                                   3.4±1.3     \<0.001                                                   
                                                                                         Feelings                     4.3±0.8                      4.1±0.9     NS                                                        4.2±0.6                                                   4.1±0.9     NS                                                        4.2±0.7                                                   4.0±1.0     NS                                                        
                                                                                         Daily activities             4.7±0.5                      4.5±0.7     NS                                                        4.7±0.4                                                   4.6±0.6     NS                                                        4.7±0.5                                                   4.5±0.6     \<0.05                                                    
                                                                                         Social activities            4.7±0.5                      4.6±0.7     NS                                                        4.6±0.7                                                   4.7±0.6     NS                                                        4.6±0.5                                                   4.4±0.8     NS                                                        
                                                                                         Change in health             3.3±0.7                      3.1±0.7     NS                                                        3.4±0.7                                                   3.3±0.7     NS                                                        3.3±0.7                                                   3.1±0.8     NS                                                        
                                                                                         Overall health               3.4±0.7                      3.1±0.7     \<0.005                                                   3.6±0.6                                                   3.2±0.7     \<0.001                                                   3.6±0.7                                                   3.1±0.7     \<0.001                                                   
                                                                                         Pain                         3.9±1.0                      3.9±1.1     NS                                                        4.1±0.9                                                   3.9±0.9     NS                                                        4.1±0.9                                                   3.9±1.0     NS                                                        
                                                                                         Quality of life              3.5±0.7                      3.2±0.6     \<0.005                                                   3.7±0.6                                                   3.3±0.8     \<0.001                                                   3.6±0.6                                                   3.3±0.7     \<0.05                                                    
  SF-36v2 (best: 100-worst: 0)                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                         Physical functioning         87.4±10.6                    69.5±23.2   \<0.001                                                   82.4±13.5                                                 67.1±22.0   \<0.001                                                   81.7±13.5                                                 64.3±24.1   \<0.001                                                   
                                                                                         Role: physical               96.2±8.9                     78.3±27.3   \<0.001                                                   92.0±13.6                                                 73.8±28.4   \<0.001                                                   92.5±13.7                                                 71.2±29.9   \<0.001                                                   
                                                                                         Bodily pain                  84.9±18.1                    75.3±27.0   \<0.05                                                    84.4±17.5                                                 73.7±23.6   \<0.005                                                   82.8±18.7                                                 73.1±25.0   \<0.05                                                    
                                                                                         General health perceptions   71.5±16.6                    53.4±20.9   \<0.001                                                   69.0±15.0                                                 49.2±19.9   \<0.001                                                   68.1±14.6                                                 47.6±20.5   \<0.001                                                   
                                                                                         Vitality                     71.0±17.6                    58.6±22.5   \<0.001                                                   71.9±14.8                                                 54.0±25.2   \<0.001                                                   71.4±18.6                                                 54.1±27.1   \<0.001                                                   
                                                                                         Social functioning           94.2±12.0                    86.0±19.9   \<0.005                                                   93.8±12.6                                                 84.6±18.7   \<0.001                                                   92.7±15.1                                                 83.1±22.5   \<0.01                                                    
                                                                                         Role: emotional              95.1±10.2                    83.6±25.7   \<0.001                                                   91.7±16.7                                                 82.0±23.8   \<0.01                                                    90.6±16.4                                                 78.3±28.3   \<0.005                                                   
                                                                                         Mental health                81.0±16.6                    77.5±18.7   NS                                                        81.8±12.0                                                 71.3±20.2   \<0.001                                                   80.9±15.4                                                 70.0±22.0   \<0.005                                                   
  Respiratory symptoms                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                         Weather affects your cough   10 (11.4)                    26 (34.7)   \<0.001^[3](#tfn6-jpmph-51-3-130){ref-type="table-fn"}^   9 (11.3)                                                  20 (29.4)   \<0.01^[3](#tfn6-jpmph-51-3-130){ref-type="table-fn"}^    11 (14.7)                                                 21 (33.3)   \<0.01^[3](#tfn6-jpmph-51-3-130){ref-type="table-fn"}^    
                                                                                         Coughing up sputum                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                      When you don't have a cold   19 (21.6)   49 (65.3)                                                 \<0.001^[3](#tfn6-jpmph-51-3-130){ref-type="table-fn"}^   17 (21.3)   42 (61.8)                                                 \<0.001^[3](#tfn6-jpmph-51-3-130){ref-type="table-fn"}^   14 (18.7)   43 (68.3)                                                 \<0.001^[3](#tfn6-jpmph-51-3-130){ref-type="table-fn"}^
                                                                                                                      First thing in the morning   13 (14.8)   36 (48.0)                                                 \<0.001^[3](#tfn6-jpmph-51-3-130){ref-type="table-fn"}^   9 (11.3)    34 (50.0)                                                 \<0.001^[3](#tfn6-jpmph-51-3-130){ref-type="table-fn"}^   7 (9.3)     28 (44.4)                                                 \<0.001^[3](#tfn6-jpmph-51-3-130){ref-type="table-fn"}^
                                                                                         Frequent wheezing            1 (1.1)                      28 (37.3)   \<0.001^[3](#tfn6-jpmph-51-3-130){ref-type="table-fn"}^   1 (1.3)                                                   21 (30.9)   \<0.001^[3](#tfn6-jpmph-51-3-130){ref-type="table-fn"}^   1 (1.3)                                                   22 (34.9)   \<0.001^[3](#tfn6-jpmph-51-3-130){ref-type="table-fn"}^   
  No. of symptoms/participant                                                            0.49±0.84                    1.85±1.37                    \<0.001     0.45±0.81                                                 1.72±1.29                                                 \<0.001     0.44±0.70                                                 1.81±1.26                                                 \<0.001                                                               

Values are presented as mean±standard deviation or number (%).

HR-QoL, health-related quality of life; COPD, chronic obstructive pulmonary disease; COOP/WONCA, Dartmouth Coop Functional Health Assessment/World Organization of National Colleges, Academies, and Academic Association of General Practitioners; SF-36v2, Short Form-36 Health Survey version 2; NS, not significant.

Welch *t*-test.

Responses to the 8-item COOP/WONCA charts were scored on a 5-point ordinal scale (5=best, 1=worst); The order of the scores of the COOP/WONCA chart were inverted from the original COOP/WONCA chart scores.

χ^2^-test.
